Cost and healthcare utilization of methicillin-resistant Staphylococcus aureus bacteremia estimated from linked antimicrobial resistance surveillance and hospital claims data in Japan.

ABSTRACT:

Objective

To compare the incremental costs and healthcare utilization of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with those of methicillin-susceptible S. aureus (MSSA) bacteremia.

Design

Retrospective cohort study using data from April 2014 to March 2015.

Setting

Antimicrobial resistance surveillance and hospital claims data from 16 Japanese hospitals.

Patients

The study included 73 patients with S. aureus bacteremia: 23 with MRSA and 50 with MSSA.

Methods

MRSA bacteremia was identified using blood cultures and drug-susceptibility tests. MRSA- and MSSA-related medical practices were evaluated. The costs were calculated and compared. All the medical costs were classified into empirical and definitive therapy peri

SUBMITTER: Shoji T 

PROVIDER: S-EPMC9726553 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature